RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
A NEW COST-EFFECTIVENESS FRAMEWORK FOR MODELING PSORIATIC ARTHRITIS TREATMENTS
Graham, C., Gunda, P., Miles, L., Jugl, SM., Palaka, E., & McBride, D. (2016). A NEW COST-EFFECTIVENESS FRAMEWORK FOR MODELING PSORIATIC ARTHRITIS TREATMENTS. Value in Health, 19(3), A233-A234. https://doi.org/10.1016/j.jval.2016.03.1151
Existing HTA submissions use a common Markov structure in evaluation of PsA treatments. Although these incorporate most aspects of disease progression, areas of improvement were identified. The proposed framework can assist decision makers in determining the cost-effectiveness of PsA treatments more effectively.